Records containing: Spinocerebellar Degeneration
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-06-27Phase III Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
-
CLINICAL_TRIALS study record update · 2023-07-24Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IV Clinical Trial to Evaluate and Compare the Efficacy and Safety of C-Trelin OD Tab 5mg(Taltirelin Hydrate) in Patients With Ataxia Induced by Spinocerebellar Degeneration
-
CLINICAL_TRIALS study record update · 2018-12-14An Additional Phase III Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
-
CLINICAL_TRIALS study record update · 2018-12-14A Phase III Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
-
CLINICAL_TRIALS study record update · 2016-04-18ClinicalTrials.gov study NCT01970137
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-04-18ClinicalTrials.gov study NCT01970124
-
CLINICAL_TRIALS study record update · 2016-04-18ClinicalTrials.gov study NCT01970111
-
CLINICAL_TRIALS study record update · 2010-09-28A Double-blind, Placebo-controlled, Crossover Study, Followed by Open-label Study of KPS-0373 in Patients With SCD
-
CLINICAL_TRIALS study record update · 2010-02-03An Open-label, Phase II Study of KPS-0373 in Patients With SCD